The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
S-1 as adjuvant chemotherapy for stage III colon cancer: Updated outcomes of ACTS-CC trial.
 
Yusuke Kinugasa
Honoraria - Bayer Yakuhin; Chugai Pharma; Covidien; Japan Medical; Johnson & Johnson; Kyowa Hakko Kirin; Stryker; Taiho Pharmaceutical; Takeda
Research Funding - Yakult Honsha (Inst)
 
Megumi Ishiguro
Honoraria - Chugai Pharma; Nippon Kayaku; Taiho Pharmaceutical; Yakult Honsha
Consulting or Advisory Role - Taiho Pharmaceutical
Research Funding - Taiho Pharmaceutical (Inst)
 
Eiji Nakatani
No Relationships to Disclose
 
Takeshi Endo
No Relationships to Disclose
 
Hiroharu Shinozaki
No Relationships to Disclose
 
Yasumasa Takii
Honoraria - Bayer Yakuhin; Bristol-Myers Squibb; Chugai Pharma; Kaken Pharmaceutical; Merck Serono; Taiho Pharmaceutical; Takeda
 
Yu Takahashi
No Relationships to Disclose
 
Hidetaka Mochizuki
Honoraria - Taiho Pharmaceutical
Consulting or Advisory Role - Otsuka
 
Kenjiro Kotake
Honoraria - Bayer Yakuhin; Bristol-Myers Squibb; Chugai Pharma; Taiho Pharmaceutical; Yakult Honsha
 
Shingo Kameoka
Research Funding - Chugai Pharma (Inst); Taiho Pharmaceutical (Inst); Yakult Honsha (Inst)
 
Keiichi Takahashi
Honoraria - Chugai Pharma; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Toshiaki Watanabe
Honoraria - Bristol-Myers Squibb; Chugai Pharma; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha
Consulting or Advisory Role - Bristol-Myers Squibb; Chugai Pharma; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha
Speakers' Bureau - Bristol-Myers Squibb; Chugai Pharma; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Bristol-Myers Squibb (Inst); Chugai Pharma (Inst); Merck Serono (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Yakult Honsha (Inst)
 
Masahiko Watanabe
Honoraria - Chugai Pharma; Taiho Pharmaceutical; Yakult Honsha
Consulting or Advisory Role - Chugai Pharma; Taiho Pharmaceutical; Yakult Honsha
Research Funding - Chugai Pharma (Inst); Taiho Pharmaceutical (Inst); Yakult Honsha (Inst)
 
Narikazu Boku
Honoraria - Ono Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - Shionogi
Research Funding - Chugai Pharma (Inst); Taiho Pharmaceutical (Inst)
 
Naohiro Tomita
Honoraria - Chugai Pharma; Merck Serono; Taiho Pharmaceutical; Yakult Honsha
 
Kenichi Sugihara
Honoraria - Bayer Yakuhin; Bristol-Myers Squibb; Chugai Pharma; Merck Serono; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Bayer Yakuhin; Bristol-Myers Squibb; Merck Serono; Takeda
Research Funding - Bayer Yakuhin (Inst); Bristol-Myers Squibb (Inst); Chugai Pharma (Inst); Merck Serono (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Yakult Honsha (Inst)